Los puntos clave no están disponibles para este artículo en este momento.
ApoA-I GT reduced the development of streptozotocin-induced diabetic cardiomyopathy.
Linthout et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: